HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful Posaconazole Therapy of Disseminated Alternariosis due to Alternaria infectoria in a Heart Transplant Recipient.

Abstract
We report a case of phaeohyphomycosis caused by Alternaria infectoria in a 61-year-old heart transplant recipient with multiple skin lesions and pulmonary infiltrates. The infection spread via the haematogenous route from the primary cutaneous lesions into the lungs. The diagnosis was based on the histopathological examination, direct microscopy, skin lesion cultures and detection of Alternaria DNA in the bronchoalveolar lavage fluid using molecular methods. The treatment consisted of a combination of surgical excision and systemic antifungal therapy. Voriconazole was the first agent used but had a weak effect. Posaconazole was subsequently used to achieve a successful response. The isolate was identified as A. infectoria by sequencing of the rDNA ITS region and the partial β-tubulin gene.
AuthorsPavlina Lyskova, Milos Kubanek, Vit Hubka, Eva Sticova, Ludek Voska, Dana Kautznerova, Miroslav Kolarik, Petr Hamal, Martina Vasakova
JournalMycopathologia (Mycopathologia) Vol. 182 Issue 3-4 Pg. 297-303 (Apr 2017) ISSN: 1573-0832 [Electronic] Netherlands
PMID27866319 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antifungal Agents
  • DNA, Fungal
  • DNA, Ribosomal Spacer
  • Triazoles
  • Tubulin
  • posaconazole
Topics
  • Alternaria (classification, drug effects, genetics, isolation & purification)
  • Antifungal Agents (therapeutic use)
  • DNA, Fungal (chemistry, genetics)
  • DNA, Ribosomal Spacer (chemistry, genetics)
  • Debridement
  • Dermatomycoses (diagnosis, drug therapy, microbiology)
  • Heart Transplantation
  • Histocytochemistry
  • Humans
  • Lung Diseases, Fungal (diagnosis, drug therapy, microbiology)
  • Male
  • Microscopy
  • Middle Aged
  • Phaeohyphomycosis (diagnosis, drug therapy, microbiology)
  • Sequence Analysis, DNA
  • Transplant Recipients
  • Treatment Outcome
  • Triazoles (therapeutic use)
  • Tubulin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: